Role of APOBEC3 in in vivo Restriction of Retrovirus Infection
APOBEC3 在体内限制逆转录病毒感染中的作用
基本信息
- 批准号:8420340
- 负责人:
- 金额:$ 36.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsApolipoproteins BB-LymphocytesBiological ModelsCellsComplexCultured CellsCytidineCytosineDNADeaminationDependovirusDevelopmentEpithelial CellsEukaryotaEvolutionFamilyGene DeletionGenesGenetic PolymorphismGenomeHIVHIV InfectionsHIV-1Hepatitis B VirusHumanHuman GenomeHuman PapillomavirusImmuneIn VitroInfectionInfection ControlInfectious AgentKnockout MiceLactationLymphoidLymphoid TissueMammary glandMediatingMilkMonkeysMouse Mammary Tumor VirusMusOrganismPathway interactionsPlayProkaryotic CellsProtein FamilyProteinsRetroviridaeRetroviridae InfectionsRoleSIVSpumavirusSystemT-LymphocyteTissuesTumor Virus InfectionsViralViral PhysiologyVirionVirusVirus DiseasesVirus Replicationbasehuman CEM15 proteinhuman tissuein vivoinsightinterestmouse modelprotein functionpublic health relevanceresearch studyresponsetransmission process
项目摘要
DESCRIPTION (provided by applicant): Infectious agents have infected prokaryotes and eukaryotes throughout evolution. Indeed, there is co-evolution among organisms and their infectious agents, with development of protective responses in the hosts and adaptive countermeasures to them by the infectious agents. One recently identified system of viral restriction is the Apolipoprotein B editing complex (APOBEC or A) family of proteins. Human APOBEC3G was first identified as an anti-viral factor in HIV infection. The human genome encodes multiple A3 proteins, including hA3G and hA3F. hA3G and hA3F restrict infection by Vif-deficient human immunodeficiency virus 1 (HIV-1). A3 proteins are packaged into virions and inhibit retroviral replication in newly infected cells, in part by deaminating cytosines on negative strand DNA intermediates and through as of yet uncharacterized mechanisms. We recently provided the first in vivo demonstration of an antiviral function for A3 proteins. We showed that mouse mammary tumor virus (MMTV) replication was inhibited by endogenous mA3 in vivo, since mice with targeted deletion of this gene were more susceptible to infection than their wild type littermates. We also showed that hA3G was packaged into MMTV virions and inhibited infection of cultured cells. We propose here to use MMTV to further probe the function of mA3 and hA3 proteins. We will examine the mechanism by which A3 proteins are packaged into virions, restrict retrovirus infection in vitro and in vivo, the role that polymorphisms in the A3 genes plays in affecting virus restriction and whether A3 expression in mammary tissue restricts milk-borne transmission of virus. As a consequence of these studies, we will know what role/s A3 proteins play in infection by exogenous viruses. These studies will provide a basis for understanding how this family of intrinsic immune factors inhibits viral infection of the mouse and other species by exogenous viruses, including HIV-1 infection of humans.
描述(由申请人提供):传染源在整个进化过程中感染了原核生物和真核生物。事实上,生物体及其传染原之间存在着共同进化,随着宿主的保护性反应的发展以及传染原对它们的适应性对策。最近发现的一种病毒限制系统是载脂蛋白 B 编辑复合物(APOBEC 或 A)蛋白家族。人类 APOBEC3G 首次被鉴定为 HIV 感染的抗病毒因子。人类基因组编码多种 A3 蛋白,包括 hA3G 和 hA3F。 hA3G 和 hA3F 限制 Vif 缺陷型人类免疫缺陷病毒 1 (HIV-1) 的感染。 A3 蛋白被包装到病毒体中,并抑制新感染细胞中的逆转录病毒复制,部分是通过负链 DNA 中间体上的胞嘧啶脱氨基以及通过尚未表征的机制。我们最近首次在体内证明了 A3 蛋白的抗病毒功能。我们发现,小鼠乳腺肿瘤病毒(MMTV)的复制在体内受到内源性 mA3 的抑制,因为定向删除该基因的小鼠比其野生型同窝小鼠更容易受到感染。我们还表明,hA3G 被包装到 MMTV 病毒体中并抑制培养细胞的感染。我们在此建议使用MMTV进一步探测mA3和hA3蛋白的功能。我们将研究A3蛋白包装成病毒颗粒、限制逆转录病毒在体外和体内感染的机制、A3基因的多态性在影响病毒限制中的作用以及乳腺组织中A3的表达是否限制病毒的乳源性传播。作为这些研究的结果,我们将了解 A3 蛋白在外源病毒感染中发挥什么作用。这些研究将为了解该固有免疫因子家族如何抑制外源病毒(包括人类的 HIV-1 感染)对小鼠和其他物种的病毒感染提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN R ROSS其他文献
SUSAN R ROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN R ROSS', 18)}}的其他基金
Interplay between reverse transcription and host restriction
逆转录与宿主限制之间的相互作用
- 批准号:
10607086 - 财政年份:2023
- 资助金额:
$ 36.68万 - 项目类别:
The role of TRIM2 and SIRPA in New World Arenavirus entry
TRIM2 和 SIRPA 在新世界沙粒病毒进入中的作用
- 批准号:
10362439 - 财政年份:2022
- 资助金额:
$ 36.68万 - 项目类别:
The role of TRIM2 and SIRPA in New World Arenavirus entry
TRIM2 和 SIRPA 在新世界沙粒病毒进入中的作用
- 批准号:
10625278 - 财政年份:2022
- 资助金额:
$ 36.68万 - 项目类别:
Role of DDX41 in HSC development and MDS/AML
DDX41 在 HSC 发育和 MDS/AML 中的作用
- 批准号:
10216402 - 财政年份:2021
- 资助金额:
$ 36.68万 - 项目类别:
Role of DDX41 in HSC development and MDS/AML
DDX41 在 HSC 发育和 MDS/AML 中的作用
- 批准号:
10373097 - 财政年份:2021
- 资助金额:
$ 36.68万 - 项目类别:
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection
APOBEC3 在体内限制逆转录病毒感染中的作用
- 批准号:
9054058 - 财政年份:2016
- 资助金额:
$ 36.68万 - 项目类别:
Role of DNA sensors in host anti-retroviral defense
DNA传感器在宿主抗逆转录病毒防御中的作用
- 批准号:
9172791 - 财政年份:2016
- 资助金额:
$ 36.68万 - 项目类别:
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection
APOBEC3 在体内限制逆转录病毒感染中的作用
- 批准号:
9176518 - 财政年份:2016
- 资助金额:
$ 36.68万 - 项目类别:
APOBEC3-mediated damage of host genomic DNA in vivo
APOBEC3 介导的体内宿主基因组 DNA 损伤
- 批准号:
8822043 - 财政年份:2015
- 资助金额:
$ 36.68万 - 项目类别:
Gordon Research Conference on "Infections of the nervous system: Pathogenesis and Worldwide Impact1"
戈登研究会议“神经系统感染:发病机制和全球影响1”
- 批准号:
8986297 - 财政年份:2015
- 资助金额:
$ 36.68万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 36.68万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 36.68万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 36.68万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 36.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 36.68万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 36.68万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 36.68万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 36.68万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 36.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 36.68万 - 项目类别:














{{item.name}}会员




